DE2607418A1 - Terpenoidester von steroiden, verfahren zu ihrer herstellung und sie enthaltende praeparate - Google Patents

Terpenoidester von steroiden, verfahren zu ihrer herstellung und sie enthaltende praeparate

Info

Publication number
DE2607418A1
DE2607418A1 DE19762607418 DE2607418A DE2607418A1 DE 2607418 A1 DE2607418 A1 DE 2607418A1 DE 19762607418 DE19762607418 DE 19762607418 DE 2607418 A DE2607418 A DE 2607418A DE 2607418 A1 DE2607418 A1 DE 2607418A1
Authority
DE
Germany
Prior art keywords
dione
methyl
retinoate
llß
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762607418
Other languages
German (de)
English (en)
Inventor
Charles J Casmer
Richard W Draper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scherico Ltd
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of DE2607418A1 publication Critical patent/DE2607418A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027Azides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • C07J71/0047Nitrogen only at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE19762607418 1975-02-28 1976-02-24 Terpenoidester von steroiden, verfahren zu ihrer herstellung und sie enthaltende praeparate Withdrawn DE2607418A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/554,351 US3984544A (en) 1975-02-28 1975-02-28 Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor

Publications (1)

Publication Number Publication Date
DE2607418A1 true DE2607418A1 (de) 1976-09-09

Family

ID=24213007

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762607418 Withdrawn DE2607418A1 (de) 1975-02-28 1976-02-24 Terpenoidester von steroiden, verfahren zu ihrer herstellung und sie enthaltende praeparate

Country Status (29)

Country Link
US (1) US3984544A (da)
JP (1) JPS51110551A (da)
AR (1) AR218851A1 (da)
AU (1) AU502298B2 (da)
BE (1) BE838923A (da)
CA (1) CA1064905A (da)
CH (1) CH629825A5 (da)
CS (1) CS195722B2 (da)
DD (1) DD125593A5 (da)
DE (1) DE2607418A1 (da)
DK (1) DK142201B (da)
ES (1) ES445488A1 (da)
FI (1) FI760472A (da)
FR (1) FR2302099A1 (da)
GB (1) GB1533614A (da)
GR (1) GR59913B (da)
HK (1) HK7082A (da)
HU (1) HU176716B (da)
IE (1) IE43452B1 (da)
IL (1) IL49103A (da)
KE (1) KE3189A (da)
LU (1) LU74421A1 (da)
NL (1) NL7601864A (da)
NO (1) NO760607L (da)
NZ (1) NZ180110A (da)
PH (1) PH13213A (da)
PT (1) PT64835B (da)
SE (2) SE7602279L (da)
ZA (1) ZA761128B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843096A (en) * 1985-06-26 1989-06-27 Stiefel Laboratories, Inc. Treatment of acne
US4885311A (en) * 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases
FR2644459B1 (fr) * 1989-03-16 1994-10-28 Oreal Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
US5648563A (en) * 1991-04-09 1997-07-15 Sloan-Kettering Institute For Cancer Research Retro-alpha-retinol derivative and uses of retro-alpha-retinol
US6992108B1 (en) * 1991-12-18 2006-01-31 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US7056954B2 (en) * 1991-12-18 2006-06-06 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
WO2004064743A2 (en) * 2003-01-17 2004-08-05 Wisconsin Alumni Research Foundation Modified retinoid compounds and their uses
JP2005020400A (ja) * 2003-06-26 2005-01-20 Hitachi Communication Technologies Ltd 無線基地局、無線通信システム、無線基地局の通信制御方法、および、無線通信網の構築方法
CA2513586A1 (en) * 2003-01-17 2004-08-05 Wisconsin Alumni Research Foundation Method of reducing toxicity of retinoids
WO2008070116A2 (en) * 2006-12-04 2008-06-12 Concert, Llc Topical compositions for treatment of skin conditions
US20090203628A1 (en) * 2008-02-12 2009-08-13 Jan Marini Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition
UA116622C2 (uk) 2011-11-11 2018-04-25 Аллерган, Інк. Похідні 4-прегенен-11ss-17-21-тріол-3,20-діону для лікування хвороб очей

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1530972A (fr) * 1966-07-15 1968-06-28 Angeli Inst Spa Procédé de préparation d'esters de stéroïde
US3780177A (en) * 1967-06-16 1973-12-18 Warner Lambert Co 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use

Also Published As

Publication number Publication date
PH13213A (en) 1980-02-07
IL49103A0 (en) 1976-04-30
FI760472A (da) 1976-08-29
CA1064905A (en) 1979-10-23
DD125593A5 (da) 1977-05-04
IE43452B1 (en) 1981-02-25
SE7901000L (sv) 1979-02-05
US3984544A (en) 1976-10-05
SE7602279L (sv) 1976-08-30
HU176716B (en) 1981-04-28
GB1533614A (en) 1978-11-29
ZA761128B (en) 1977-02-23
GR59913B (en) 1978-03-20
DK142201B (da) 1980-09-22
IE43452L (en) 1976-08-28
CS195722B2 (en) 1980-02-29
FR2302099B1 (da) 1978-11-10
FR2302099A1 (fr) 1976-09-24
PT64835B (en) 1977-06-07
AU1142076A (en) 1977-09-01
DK142201C (da) 1981-03-02
IL49103A (en) 1979-12-30
NZ180110A (en) 1978-06-20
ES445488A1 (es) 1977-11-01
AU502298B2 (en) 1979-07-19
CH629825A5 (de) 1982-05-14
NL7601864A (nl) 1976-08-31
PT64835A (en) 1976-03-01
KE3189A (en) 1982-04-02
LU74421A1 (da) 1977-01-07
NO760607L (da) 1976-08-31
DK79976A (da) 1976-08-29
HK7082A (en) 1982-02-26
AR218851A1 (es) 1980-07-15
JPS51110551A (da) 1976-09-30
BE838923A (fr) 1976-08-25

Similar Documents

Publication Publication Date Title
DE2707336C2 (da)
EP0135476B1 (de) Steroid Carbonsäureester
DE1443957B1 (de) 9 alpha-Chlor- bzw. 9 alpha-Fluor-16 beta-methyl-prednisolon-17,21-diester und ein Verfahren zu deren Herstellung
CH619968A5 (da)
DE2607418A1 (de) Terpenoidester von steroiden, verfahren zu ihrer herstellung und sie enthaltende praeparate
DE2512915A1 (de) 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung
CH505802A (de) Verfahren zur Herstellung von Estern von 17a-Hydroxysteroiden der Pregnanreihe
DE2538595A1 (de) Steroidverbindungen
CH537917A (de) Verfahren zur Herstellung von 20-Hydroperoxysteroiden
CH504423A (de) Verfahren zur Herstellung von 17a-Mono-kohlenwasserstoffcarbonsäureestern von 9a, 11B-Dihalogen-16a-niedrigalkyl-1,4-pregnadien-17a, 21-diol-3,20-dionen und ihren 4-Pregnen-Analoga
EP0003341B1 (de) 11,17-substituierte Pregnane, ihre Herstellung und Verwendung zur Herstellung von pharmazeutischen Präparaten
DE2365992C3 (de) 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung
DE2852055C2 (da)
CH655320A5 (de) Verfahren zur herstellung von corticosteroid-estern mittels selektiver solvolyse.
EP0032103B1 (de) Neue Kortikoid-17-thioacetale, ihre Herstellung und Verwendung
CH626633A5 (da)
CH625254A5 (da)
DE1793749C3 (de) Verfahren zur Herstellung von 1,4-Diensteroiden
DE1768673C (de) 6 alpha, 9 alpha-Difluorprednisolon-17,21-diester
EP0012271B1 (de) Neue Prednison-Derivate, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende pharmazeutische Präparate und deren Verwendung
DE2848423A1 (de) Hydrocortisonester, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
DE1768673B1 (de) 6alpha,9alpha-Difluorprednisolon-17,21-diester
DE1802962C3 (de) Neue Galpha, 6beta-Dlfluorsteroide, Verfahren zu ihrer Herstellung, sowie diese enthaltende Mittel
DE2508136C3 (de) Neue Steroide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
DE1593518C3 (de) Verfahren zur Herstellung eines 17 alpha-Esters der Pregnanreihe

Legal Events

Date Code Title Description
8141 Disposal/no request for examination